We report on the combined use of endogenous two-photon intensity and lifetime based fluorescence measurements to identify changes in specific metabolic pathways. Such functional insights can improve understanding of disease development and drug effects.
© 2018 The Author(s)
You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.
Contact your librarian or system administrator
Login to access OSA Member Subscription